Rebecca Auer

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute
Professor, Department of Surgery and Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa
Surgical Oncologist, Faculty of Medicine, Department of Biochemistry, Immunology & Microbiology, The Ottawa Hospital
Tier 2 Clinical Research Chair, Perioperative Cancer Therapeutics, University of Ottawa
Scientific Director, Cancer Therapeutics Program, Ottawa Hospital Research Institute

Full Biography

Cancers of Interest

Peritoneal solid tumors

Research Interests and Clinical Approach

Perioperative immunotherapy
ICV immunotherapy

Projects at BioCanRx

COV-IMMUNO- A randomized phase III trial of immunization with IMM-101 versus observation for the prevention of serious respiratory and COVID-19 related infections in cancer patients at increased risk of exposure

Optimizing a personalized infected cell vaccine (ICV) for peritoneal carcinomatosis

Recent Articles

Pancreatic cancer loses viral defences when talking with supporting cells

Successful Fourth Summit for Cancer Immunotherapy

The Ottawa Regional Cancer Foundation Invests $100,000 in BioCanRx Research Projects

Pancreatic cancer loses viral defences when talking with supporting cells

Successful Fourth Summit for Cancer Immunotherapy

Dr. Rebecca Auer receives grant from Canadian Cancer Society

Introducing the winners of BioCanRx’s 2019 Summer Studentships

Diving deep into the abdominal cavity

Introducing the winners of BioCanRx’s 2018 Summer Studentships

Announcing the winners of BioCanRx’s 2017 Summer Studentships